Can anything be done to bring down prescription drug costs?

Congress is working on measures to bring down prescription drug costs. But Prescryptive CEO, Chris Blackley, says more is needed before consumers see lower prices. “As long as PBMs are controlling market access for affordable options and inhibiting competition through practices like spread pricing, verticalization, and bundling, drug costs will not go down,” he said. Continue reading this story in Consumer Affairs.